Literature DB >> 2935958

Cancer chemotherapeutics as immunomodulators.

F Spreafico, A Vecchi, F Colotta, A Montovani.   

Abstract

Mesh:

Substances:

Year:  1985        PMID: 2935958     DOI: 10.1007/bf01857390

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN: 0344-4325


× No keyword cloud information.
  62 in total

1.  Mechanisms of corticosteroid action on lymphocyte subpopulations. V. Effects of in vivo hydrocortisone on the circulatory kinetics and function of naturally occuring and mitogen-induced suppressor cells in man.

Authors:  B F Haynes; P Katz; A S Fauci
Journal:  Cell Immunol       Date:  1979-04       Impact factor: 4.868

2.  Interaction of antitumor drugs with human erythrocyte ghost membranes and mastocytoma P815: a spin label study.

Authors:  B K Sinha; C F Chignell
Journal:  Biochem Biophys Res Commun       Date:  1979-02-28       Impact factor: 3.575

3.  Phase I and pharmacological studies of adriamycin administered intraperitoneally to patients with ovarian cancer.

Authors:  R F Ozols; R C Young; J L Speyer; P H Sugarbaker; R Greene; J Jenkins; C E Myers
Journal:  Cancer Res       Date:  1982-10       Impact factor: 12.701

4.  Augmentation of the human immune response by cyclophosphamide.

Authors:  D Berd; M J Mastrangelo; P F Engstrom; A Paul; H Maguire
Journal:  Cancer Res       Date:  1982-11       Impact factor: 12.701

5.  Multiple tumoricidal effector mechanisms induced by adriamycin.

Authors:  D Salazar; S A Cohen
Journal:  Cancer Res       Date:  1984-06       Impact factor: 12.701

6.  In vitro and in vivo cytotoxicity of adriamycin and daunomycin for murine macrophages.

Authors:  A Mantovani
Journal:  Cancer Res       Date:  1977-03       Impact factor: 12.701

7.  Tumoricidal activity of macrophages isolated from human ascitic and solid ovarian carcinomas: augmentation by interferon, lymphokines and endotoxin.

Authors:  G Peri; N Polentarutti; C Sessa; C Mangioni; A Mantovani
Journal:  Int J Cancer       Date:  1981-08-15       Impact factor: 7.396

8.  Activation of human B lymphocytes. XII. Differential effects of in vitro cyclophosphamide on human lymphocyte subpopulations involved in B-cell activation.

Authors:  H C Stevenson; A S Fauci
Journal:  Immunology       Date:  1980-03       Impact factor: 7.397

9.  Mechanisms of target recognition and destruction in macrophage-mediated tumor cytotoxicity.

Authors:  D O Adams; W J Johnson; P A Marino
Journal:  Fed Proc       Date:  1982-04

10.  Genetic control of specific immune suppression. IV. Responsiveness to the random copolymer L-glutamic acid50-L-tyrosine50 induced in BALB/c mice by cyclophosphamide.

Authors:  P Debré; C Waltenbaugh; M E Dorf; B Benacerraf
Journal:  J Exp Med       Date:  1976-07-01       Impact factor: 14.307

View more
  1 in total

1.  Cellular Mechanism of Newly Synthesized Indoledione Derivative-induced Immunological Death of Tumor Cell.

Authors:  Su-Jin Oh; Chung-Kyu Ryu; So-Young Baek; Hyunah Lee
Journal:  Immune Netw       Date:  2011-12-31       Impact factor: 6.303

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.